Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Census population 486,051. Nebraska Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Omaha clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Omaha storefront.
PRP Wound Care Technology in Omaha, NE for clinics & physicians. PRP wound care accelerates healing for ch… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Obesity 37.5%; arthritis 21.4%. Those three PLACES crude rates (plus Census 486,051) are the local facts on this page. Everything else is the national prp wound care catalog and J5 paperwork.
National PRP Wound Care Technology notes (how the product actually works)12% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 486,051 residents will still mix those payers. CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Omaha trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 10.2% of adults — 1.8 points below the U.S. 12% figure. Obesity is 37.5%; arthritis is 21.4%. That is place-level BRFSS modeling, not a clinic census and not a Omaha trial.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Bring specialty, monthly wound volume, and whether you bill J5 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 10.2% diabetes and 21.4% arthritis for Omaha — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Omaha, NE.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Omaha is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Omaha — 1.8 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Nebraska Part B wound biologics follow this contractor (siblings: IA, KS, MO). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Omaha. Useful for joint-program math; still needs a diagnosis and privileging.
No Omaha storefront. Joe Bradley is an active practice owner. prp wound care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.